newsfilter
← Latest News
PR Newswire·

Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and...